Recap: Usana Health Sciences Q2 Earnings


Shares of Usana Health Sciences USNA fell in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were up 41.67% year over year to $1.87, which beat the estimate of $1.71.

Revenue of $336,837,000 up by 30.06% from the same period last year, which beat the estimate of $332,610,000.


Usana Sees FY21 EPS $6.15-$6.50 vs $6.37 Estimate, Sales $1.24B-$1.28B vs $1.27B Est.


52-week high: $107.85

Company's 52-week low was at $72.03

Price action over last quarter: Up 13.39%

Company Overview

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe, with the majority of its revenue generated from markets outside the United States.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!